Propanc Biopharma

PPCBNasdaq Australia Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.205 M

$1.20 -11.77%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$58.9M

Loss-making

Shares outstanding

15,859,280

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#476Dermata TherapeuticsDRMA$4.42M
#477CapstoneCAPS$4.29M
#478Propanc BiopharmaPPCB$4.20M
#479Transcode TherapeuticsRNAZ$4.19M
#480PMGCELAB$4.16M

Where these numbers come from

Share counts and financials for Propanc Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.